Results 191 to 200 of about 62,976 (303)

What Is Your Diagnosis? Blood Smear From a Mixed‐Breed Dog

open access: yes
Veterinary Clinical Pathology, EarlyView.
Laura S. Peres   +5 more
wiley   +1 more source

Remodelling of Skeletal Muscle During Iron Deficiency Anaemia and Recovery After Intravenous Iron Therapy

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 6, December 2026.
ABSTRACT Background The global prevalence of iron deficiency anaemia (IDA) is about 25% and even higher in women of reproductive age and children. IDA can impair skeletal muscle by disrupting oxygen utilization, energy production and contractile function. Haematological effects of intravenous (IV) iron therapy in IDA are well studied, but its impact on
Elke Pertler   +18 more
wiley   +1 more source

Integrating anaerobic and photochemical processes: UV–vis‐driven post‐treatment for micropollutant abatement and toxicity control in UASB secondary effluent

open access: yesJournal of Chemical Technology &Biotechnology, Volume 101, Issue 12, Page 2619-2629, December 2026.
Abstract BACKGROUND Upflow anaerobic sludge blanket (UASB) reactors are widely used in low‐ and middle‐income countries, but secondary effluents may still contain organic micropollutants and residual toxicity. This study evaluated UV–Vis photolysis and UV/H2O2 as post‐treatment options for UASB secondary effluent (SE), integrating micropollutant ...
Fernando Rodrigues‐Silva   +10 more
wiley   +1 more source

Aphid Resistance in Pulse Crops: Sources, Mechanisms, Genetics and Breeding

open access: yesLegume Science, Volume 8, Issue 4, December 2026.
ABSTRACT Aphids are major pests of pulse crops, causing damage through phloem sap feeding and virus transmission. In this context, resistant varieties are central components of sustainable aphid management. This review synthesizes current knowledge on resistance sources, phenotyping strategies, resistance mechanisms, genetic control and breeding ...
Francisco A. Mendes   +3 more
wiley   +1 more source

A Biweekly GLP‐1R Agonist Designed With Drug‐Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 11143-11177, December 2026.
ABSTRACT Aim To develop a next‐generation, longer‐acting, more‐clinical‐benefits agonist to achieve sustained efficacy with improved tolerability. Methods CT130 was designed from semaglutide. Binding affinity was validated via molecular dynamics and cellular assays.
Wei Ding   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy